5 completed, 3 active not recruiting, 2 recruiting, 1 unknown. 9 Not applicable, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 9 | Active not recruiting 3, Completed 3, Recruiting 2, Withdrawn 1 |
| Phase 1 | 1 | Completed 1 |
Follow Cervical Biopsy: new trials by email Literature Review of Cervical Biopsy trials Research Report on Cervical Biopsy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparison Of Cytology And Molecular Screening For Detecting Cervical Reactive Cellular Changes In General Population Physical examination, Liquid-based cytology, Molecular screening - Atypical Squamous Cell of Undetermined Significance, ASC-US | Not applicable | Withdrawn | Timser SAPI de CV | 2026-02-27 | 2026-03-03 | |
| Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S04) Biospecimen Collection, Cervical Biopsy, Colposcopy - Cervical Carcinoma, Human Papillomavirus Infection | Not applicable | Recruiting | National Cancer Institute (NCI) | 500 | 2025-11-24 | 2026-07-31 |
| Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S02) Biospecimen Collection, Cervical Biopsy, Colposcopy - Cervical Carcinoma, Human Papillomavirus Infection | Not applicable | Active not recruiting | National Cancer Institute (NCI) | 500 | 2024-09-13 | 2026-10-29 |
| Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S03) Biospecimen Collection, Cervical Biopsy, Colposcopy - Cervical Carcinoma, Human Papillomavirus Infection | Not applicable | Active not recruiting | National Cancer Institute (NCI) | 500 | 2024-09-11 | 2026-10-29 |
| Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S01) Biospecimen Collection, Cervical Biopsy, Colposcopy - Cervical Carcinoma, Human Papillomavirus Infection | Not applicable | Active not recruiting | National Cancer Institute (NCI) | 750 | 2024-06-26 | 2026-09-29 |
| Cervical Cancer Screening of Postmenopausal Women in Low- and Middle-income Countries Using HPV Self-sampling and Triage by Genotyping and Cytology Vaginal specimens for HPV test will be collected by participants themselves using flocked swabs after explanations by co-investigators. - Cervical Cancer Screening, HPV Infections | Completed | University Hospital, Geneva | 500 | 2024-06-01 | 2026-01-21 | |
| Impact of HPV on a Cohort of Southern Italian Women: Epidemiological, Clinical, Morphological and Microbiological Features Cervical biopsy - Cervix Cancer | Not applicable | Completed | University of Campania Luigi Vanvitelli | 150 | 2019-01-04 | 2023-04-13 |
| Promoting Comprehensive Cervical Cancer Prevention and Better Women Health in Cameroon HPV Test - Cervical Cancer | Not applicable | Completed | Prof. Patrick Petignat | 4473 | 2018-10-01 | 2025-01-15 |
| Automated Cervical Cancer Screening Using a Smartphone-based Artificial Intelligence Classifier AVC test - Cervical Cancer, HPV | Not applicable | Recruiting | Prof. Patrick Petignat | 5886 | 2018-08-01 | 2025-01-29 |
| Histopathological Findings in Symptomatizing Patients After Supracervical Hysterectomy Cervical biopsy - CIN, Cancer of Cervix | Not applicable | Completed | Tanta University | 88 | 2017-12-01 | 2021-04-06 |
| Retrospective Study on the Evolution of CIN 1 to 3 in Per and Postpartum in Nancy From 2014 to 2022 cervical biopsy - Cervical Intraepithelial Neoplasia | Unknown | Central Hospital, Nancy, France | 100 | 2014-01-01 | 2022-10-26 | |
| Safety Study of Nelfinavir + Cisplatin + Pelvic Radiation Therapy to Treat Cervical Cancer Nelfinavir, Cisplatin, Pelvic External Beam Radiation Therapy - Cervical Cancer | Phase 1 | Completed | University of Miami | 8 | 2012-01-01 | 2015-06-03 |
Uterine Cervical Neoplasms (10) · Papillomavirus Infections (6) · Uterine Cervical Dysplasia (3) · Neoplasms (2) · Adenocarcinoma (1) · Atypical Squamous Cells of the Cervix (1) · Uterine Cervicitis (1)
National Cancer Institute (NCI) (4) · Prof. Patrick Petignat (2) · Central Hospital, Nancy, France (1) · Tanta University (1) · Timser SAPI de CV (1) · University Hospital, Geneva (1) · University of Campania Luigi Vanvitelli (1) · University of Miami (1)
United States (5) · Cameroon (2) · Puerto Rico (2) · Egypt (1) · France (1) · Italy (1) · Mexico (1) · Switzerland (1)
Vikrant V Sahasrabuddhe (4) · J. Matthew Pearson, MD (1) · Leopoldo E Gatica-Galina, MD in OB/GY & Gynecol Oncol (1) · Patrick Petignat (1)
PMID 34914727, PMID 35109806, PMID 35379615, PMID 36549727, PMID 41420163
2017 (2)